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Abstract. It is generally well accepted that transmission
(TX)-based non-uniform attenuation correction can sup-
ply more accurate absolute quantification; however,
whether it provides additional benefits in routine clinical
diagnosis based on qualitative interpretation of 3D brain
positron emission tomography (PET) images is still the
subject of debate. The aim of this study was to compare
the effect of the two major classes of method for deter-
mining the attenuation map, i.e. uniform versus non-uni-
form, using clinical studies based on qualitative assess-
ment as well as absolute and relative quantitative volume
of interest-based analysis. We investigated the effect of
six different methods for determining the patient-specific
attenuation map. The first method, referred to as the uni-
form fit-ellipse method (UFEM), approximates the out-
line of the head by an ellipse assuming a constant linear
attenuation factor (µ=0.096 cm−1) for soft tissue. The
second, referred to as the automated contour detection
method (ACDM), estimates the outline of the head from
the emission sinogram. Attenuation of the skull is ac-
counted for by assuming a constant uniform skull thick-
ness (0.45 cm) within the estimated shape and the correct
µ value (0.151 cm−1) is used. The usual measured trans-
mission method using caesium-137 single-photon sourc-
es was used without (MTM) and with segmentation of
the TX data (STM). These techniques were finally com-
pared with the segmented magnetic resonance imaging
method (SMM) and an implementation of the inferring
attenuation distributions method (IADM) based on the
digital Zubal head atlas. Several image quality parame-
ters were compared, including absolute and relative
quantification indexes, and the correlation between them
was checked. The qualitative evaluation showed no sig-
nificant differences between the different attenuation
correction techniques as assessed by expert physicians,
with the exception of ACDM, which generated artefacts
in the upper edges of the head. The mean squared error
between the different attenuation maps was also larger
when using this latter method owing to the fact that the
current implementation of the method significantly over-
estimated the head contours on the external slices. Corre-
lation between the mean regional cerebral glucose me-
tabolism (rCGM) values obtained with the various atten-
uation correction methods and those obtained with the
gold standard (MTM) was good, except in the case of
ACDM (R 2=0.54). The STM and SMM methods
showed the best correlation (R 2=0.90) and the regression
lines agreed well with the line of identity. Relative dif-
ferences in mean rCGM values were in general less than
8%. Nevertheless, ANOVA results showed statistically
significant differences between the different methods for
some regions of the brain. It is concluded that the attenu-
ation map influences both absolute and relative quantita-
tion in cerebral 3D PET. Transmission-less attenuation
correction results in a reduced radiation dose and makes
a dramatic difference in acquisition time, allowing in-
creased patient throughput.
Keywords: Positron emission tomography – Brain imag-
ing – Attenuation map – Attenuation correction – Quan-
tification
Eur J Nucl Med Mol Imaging (2004) 31:52–63
DOI 10.1007/s00259-003-1325-8
Introduction
Attenuation correction is a crucial step in both qualita-
tive assessment and quantitative analysis of reconstruct-
ed positron emission tomography (PET) images. Infor-
mation about patient-specific tissue attenuating proper-
ties can be derived from different methods, but is more
Habib Zaidi (✉)
Division of Nuclear Medicine, Geneva University Hospital,
1211 Geneva 4, Switzerland
e-mail: habib.zaidi@hcuge.ch
Tel.: +41-22-3727258, Fax: +41-22-3727169
Original article
Attenuation compensation in cerebral 3D PET: 
effect of the attenuation map on absolute 
and relative quantitation
Habib Zaidi, Marie-Louise Montandon, Daniel O. Slosman
Division of Nuclear Medicine, Geneva University Hospital, Geneva 4, Switzerland
Received: 21 May 2003 / Accepted: 4 August 2003 / Published online: 22 October 2003
© Springer-Verlag 2003
commonly estimated by acquiring an additional pre-
injection transmission (TX) scan using external sources.
Approaches described in the literature based on trans-
mission scanning use either radionuclide positron 
(germanium-68) or single-photon (caesium-137) emit-
ting sources or alternatively X-ray tubes [1]. Although
necessary, this additional procedure complicates the
scanner design and increases the radiation dose to staff
and patients. Moreover, it substantially increases the
overall acquisition time, decreasing patient comfort and
scanner throughput and indirectly increasing the costs of
PET examinations. Theoretically, measured transmission
images introduce the least bias. While the clinical rele-
vance of non-uniform attenuation correction is well es-
tablished in thoracic imaging, it is still the subject of
heated debate in brain scanning, where in most cases
clinical diagnosis is based on qualitative assessment of
PET images [2, 3, 4, 5, 6]. In principle, brain PET stud-
ies simplify this task owing to the homogeneous charac-
teristics of tissue components in the head region [4].
This fact has motivated the development of approximate
methods to correct for attenuation with the aim of par-
tially minimising some of the side-effects described
above. Calculated methods are at the top of this simplifi-
cation scheme. Among the techniques that have found
widespread use within this class of methods is the inter-
active contour-drawing method, which consists in manu-
ally fitting an ellipse around the scalp from preliminary
2D reconstructions of uncorrected PET images. While
easy to implement, manual contour delineation is error
prone and operator dependent since inter- and intra-sub-
ject variability is unavoidable.
Automatic edge detection algorithms define the exter-
nal head contour from the emission (EM) sinograms, al-
lowing assignment of known attenuation coefficients to
the different tissues considered (e.g. brain and surround-
ing skull) [7]. More refined algorithms make use of an
automated method to compute a three-component attenu-
ation map for brain PET imaging [8]. The algorithm gen-
erates an estimated skull image by filtered backprojec-
tion of the reciprocal of an emission sinogram whose
thickness and radius are estimated from profiles extract-
ed from this image. In general, this type of approach is
advantageous in terms of overall acquisition time, and it
allows the avoidance of misalignment between EM and
TX images. On the other hand, invalid assumption of tis-
sue uniformity might lead to significant activity quantita-
tion bias, especially in regions of high variability, such
as air cavities and nasal sinuses. A completely different
and relatively new approach overcomes this problem by
inferring anatomy from a head atlas [9]. There is, how-
ever, a rather important conceptual limitation to this
technique, namely the existence of patient-specific
anomalies that are obviously not modelled in an atlas ob-
tained from a single or even an average representation of
the population. More importantly, successful intramodal-
ity image registration strongly relies on many parame-
ters, and errors resulting from misregistration could re-
sult in significant artefacts. For instance, studies have
shown that a co-registration between PET and magnetic
resonance (MR) images has an accuracy limit of approx-
imately 2 mm, which is fairly large, considering that
structures of only a few millimetres are often of interest.
Assuming that a perfect registration could be obtained
between MRI and PET, we proposed a new method to
construct the attenuation map from co-registered seg-
mented T1-weighted MRI [10].
The challenging issue of assessing differences be-
tween the effectiveness of uniform versus non-uniform
attenuation maps has been largely studied in single-pho-
ton emission tomography (SPET) [2, 11, 12, 13, 14].
Similarly, the paradoxical effect of the complexly shaped
skull base surrounding the lower half of the human brain
in lowering the mean effective broad-beam attenuation
coefficient is well understood in SPET imaging [5, 15,
16]. However, very few studies have been performed to
characterise this effect using 3D PET data. Comparisons
of more than two methods for determining the attenua-
tion map are rarely found [17], and they generally in-
clude combinations with other degrading effects, such as
scatter or partial volume effect. The aim of this study
was to compare the effect of six different methods be-
longing the two major classes of method for determining
the attenuation map, i.e. non-uniform versus uniform, us-
ing clinical 3D brain PET studies based on qualitative
assessment as well as absolute and relative quantitative
volume of interest (VOI)-based analysis.
Materials and methods
Methods for determination of the attenuation map
Uniform fit-ellipse method (UFEM). The first calculated method
approximates the outline of the head by a slice-dependent ellipse
assuming a constant linear attenuation factor (µ=0.096 cm–1) for
brain tissue [4]. The method is simple but requires an additional
preliminary 2D reconstruction of uncorrected PET data, allowing
operator interaction to manually draw an ellipse, which in our case
was performed by an experienced nuclear medicine technologist.
Automated contour detection method (ACDM). The second calcu-
lated method aims at diminishing the subjective effect of operator
dependency by using an automatic edge detection algorithm to es-
timate the external contour of the head from the emission sino-
grams [7]. Two regions are then identified and assigned corre-
sponding attenuation coefficients: brain tissue and skull. Attenua-
tion of the skull is estimated by assuming a certain uniform skull
thickness (0.45 cm) within the estimated shape and the correct lin-
ear attenuation coefficient (µ=0.151 cm−1) is applied. It is worth
emphasising that while the method identifies accurately the head
outline in the majority of central slices using a threshold fixed to
15%, it significantly overestimates the contour in the external slic-
es, leading to visible artefacts on the edges of the reconstructed
sagittal slices.
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Measured transmission method (MTM). The method used in clini-
cal routine in our department for attenuation correction is based on
the acquisition of an additional pre-injection TX scan (10 min) us-
ing 137Cs single-photon sources. A thermoplastic face mask is
used to limit head motion and for accurate repositioning of pa-
tients for the emission scan. The TX data are normalised to a slab
phantom scan and corrected for scatter and cross-section variation
using a log-linear transformation of the attenuation factors [18].
The images reconstructed with TX-based attenuation correction
served as the gold standard for comparative assessment of the dif-
ferent attenuation correction methods.
Segmented transmission method (STM). Segmentation of the trans-
mission data has been traditionally performed when using a short
transmission scanning acquisition time with the goal of reducing
noise in the associated attenuation-corrected emission data by lim-
iting its propagation through the reconstruction process [19]. In
this study, segmentation of the transmission images was per-
formed using an adaptive local histogram-based thresholding tech-
nique [20].
Segmented MRI-guided method (SMM). For all patients studied, a
high-resolution 3D T1-weighted MRI head scan was also available
through the picture archiving and communication system (PACS),
which provides an infrastructure for various kinds of medical im-
age retrieval that can be used through the hospital’s local area net-
work. The scalp, skull and meninges were removed prior to regis-
tration between MRI and PET images using a semi-automated
brain extraction tool. This step is recommended when registering
intermodality images since the algorithm strongly relies on equiv-
alence between tissue types, and these structures are obviously not
present in PET scans. MRI-PET co-registration was performed us-
ing the Automatic Image Registration (AIR 3.08) algorithm, con-
sisting in a general linear rescaling [21]. Transformation matrices
were recorded and re-applied to the original MR images. A fast
implementation of the fuzzy c-means (FCM) segmentation algo-
rithm, already validated for segmentation of transmission images
[19], was then used to classify the MRI head tissues into main
components in terms of soft tissue contrast. This procedure was
followed by appropriate assignment of attenuation coefficients ac-
cording to the method described by Zaidi et al. [10].
Inferring attenuation distributions method (IADM). This method
was originally proposed by Stodilka et al. [9] for SPET brain im-
aging and has been adapted for PET without any modifications
(e.g. adding the bed image to the final attenuation map) [17]. The
methodology that we followed was practically the same as that
proposed by Stodilka et al.; however, registration of emission im-
ages to the three-dimensional Zubal head atlas [22] was best
achieved in our case using a non-linear warping algorithm [21],
rather than a global rescaling (seven-parameter model) as used in
ref. [9]. IADM was derived by registering the brain component of
the digital head atlas with a source distribution having specific ac-
tivities of the grey matter, white matter and ventricles of 4:1:0, re-
spectively, to a preliminary PET reconstruction and then applying
the resulting spatial transformation to the full head atlas. The latter
was used to construct a patient-specific attenuation map by assign-
ing known attenuation coefficients to different head tissues, simi-
lar to the approach followed in SMM [10].
Clinical data acquisition and reconstruction
As the main focus of this study was comparison of different attenu-
ation correction schemes within subjects, patient selection was lim-
ited to those having clinically indicated cerebral PET scans. A total
of ten patients admitted for evaluation of surgical relief of their epi-
lepsy were selected from our clinical database and used for com-
parative assessment of different attenuation correction techniques.
All patients included in the study gave their written informed con-
sent for participation. Selection was restricted to patients who had
previously undergone a brain MRI scan. The emission study
(25 min) started 30 min after intravenous injection of approximate-
ly 222 MBq of fluorine-18 fluorodeoxyglucose (FDG). All data
sets were acquired in 3D mode with a maximum acceptance angle
corresponding to 17 rings and a span of 7 on an ECAT ART PET
scanner (CTI PET Systems, Knoxville, TN) upgraded to use colli-
mated 137Cs single-photon point sources for TX scanning. Ac-
quired projection data were pre-corrected for scatter using the latest
numerical implementation of the single-scatter simulation algo-
rithm [23] supplied with the ECAT 7.2 software provided by the
scanner manufacturer. Attenuation correction factors were generat-
ed by forward projecting the constructed attenuation maps obtained
using the six different methods described in the previous section
without any extra smoothing. The re-projection algorithm (3DRP)
used routinely for reconstruction of clinical brain studies in our di-
vision was used (Ramp filter, cut-off frequency 0.35 cycles/pixel),
resulting in 47 slices consisting of 128×128 matrices with a zoom
factor of 3 (voxel size, 1.716×1.716×3.375 mm3).
Patients’ anatomy was defined using a high-resolution 3D T1-
weighted MR sequence performed on a 1.5-T Eclipse scanner
(Philips Medical Systems, Best, The Netherlands). A three-dimen-
sional volumetric acquisition of a T1-weighted gradient echo se-
quence produced a gapless series of thin sagittal sections (TE/TR,
4.4/15 ms; flip angle, 25°; acquisition matrix, 256x256x160; slice
thickness, 1.1 mm).
Comparative evaluation strategy
Qualitative and quantitative assessments of differences between
images reconstructed using different attenuation correction
schemes were carried out by visual assessment performed by
trained nuclear medicine physicians and by estimating parameters
of clinical interest, including absolute and relative regional cere-
bral glucose metabolism (rCGM). Error and bias were examined
by calculating difference images between MTM and alternative
methods for deriving the attenuation map. The mean square error
(MSE) between the different attenuation maps as compared to the
gold standard (MTM) was also assessed. Well-established figures
of merit known to have a large influence on many types of task
performance are generally used to assess image quality. The met-
rics selected in our assessment, namely contrast and noise (unifor-
mity), are used as measures of image quality. Absolute and rela-
tive quantification indexes were evaluated and the correlation be-
tween them checked. Statistical analysis was also performed to as-
sess the significance of the differences. The relative difference be-
tween rCGM estimates using the different methods and MTM
(gold standard) was defined as:
Template-based quantification is a crucial step when performing
comparative evaluation of quantitative estimates. T1-weighted
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standardised stereotactic MRI templates provided within the Sta-
tistical Parametric Mapping (SPM99) software package (Well-
come Department of Cognitive Neurology, University College
London, London, UK) [24] were used to delineate manually a total
of 20 bilateral volumes of interest (VOIs) covering the totality of
cortical and subcortical structures [10]. PET and MRI templates
supplied with SPM come already spatially normalised with respect
to the Montreal Neurological Institute (MNI) reference space [25].
Therefore, it was found convenient to register the reconstructed
images with respect to the PET template. To this end, the images
were re-aligned to the standardised stereotactic template using a
nine-parameter rigid body transformation for automated VOI
quantification. Twenty VOIs were defined on the multislice MRI
template and transformed as mentioned above to the coordinate
space of the PET images to quantify FDG uptake.
Absolute quantitation. The 20 VOIs defined by an experienced
neuropsychologist were superimposed on each co-registered study,
resulting in a total of 200 VOIs for the ten patients studied. One-
way repeated ANOVA was used to test significant quantitation
differences in rCGM for each VOI when applying the different at-
tenuation correction methods under investigation. Within-group
variance was accounted for in this way since the patients were
chosen without any a priori criteria.
Relative quantitation. The derivation of physiological parameters
from semi-quantitative measures through comparison with a dis-
ease-free or receptor-void region has enabled simplified but clini-
cally achievable and highly relevant measurements. Cerebellar
normalisation is commonly reported in studies dealing with Alz-
heimer’s disease and receptor imaging [13, 14]. To assess the ef-
fect of the attenuation map on relative quantitation with respect to
cerebellum as the reference region, the mean rCGM for each VOI
was normalised to mean right and left cerebellar rCGM estimates.
Similar correlation and statistical analysis was then performed. In
addition, the contrast between the corpus callosum and lateral ven-
tricle and uniformity within the cerebellum were also compared
between the different methods. The idea of uniformity measure-
ment within the cerebellum is to minimise the deviations due to
statistical fluctuations and to measure only systematic variations
due to different attenuation correction procedures. The contrast
between the corpus callosum and lateral ventricle is of special im-
portance in certain neurological pathologies and was therefore in-
cluded in our assessment.
Results
Qualitative assessment
Representative planes (superior, middle and inferior) of
attenuation maps generated using the different methods
for a clinical brain PET study are shown in Fig. 1. It is
worth noting the slight rotational misregistration be-
tween the transmission and emission (TX-EM) scans for
this patient. In fact, the misregistration between emission
and transmission scans is reflected by a clearly visible
rotational misregistration between the MTM and ACDM
attenuation maps shown in Fig. 1, the latter being com-
puted from the emission scan. This misalignment is well
recovered by both SMM and IADM procedures. The
MRI-PET co-registration algorithm seems to produce
smaller errors compared with TX-EM, even when a ther-
moplastic face mask is used for reproducible patient po-
sitioning. Non-uniformities of the attenuation map are
obvious on planes containing sinus and air cavities. In
theory, the advantages of transmission scanning are well
established though segmented MRI appears to better re-
solve these structures. It was observed that the user-
Fig. 1. Three different transaxial planes of a patient study illustrat-
ing attenuation maps derived using the different methods. From
top to bottom: superior, middle and inferior planes, and from left
to right: UFEM, ACDM, MTM, STM, SMM and IADM
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dependent UFEM method overestimates the head con-
tour on the majority of slices. This is more pronounced
in the case of ACDM, especially on the external planes.
In addition, the assignment of theoretical attenuation co-
efficient of bone (µ=0.151 cm−1) is not straightforward
since smaller values are generally observed on clinical
transmission scans (µ=0.136±0.08 cm−1) [8].
Corresponding reconstructed PET images are illustrat-
ed in Fig. 2. The qualitative assessment was restricted to
subjective observer rating scores performed by expert
Fig. 2. Three different transaxial PET images of a patient study reconstructed using the different attenuation correction techniques. From
top to bottom: superior, middle and inferior planes, and from left to right: UFEM, ACDM, MTM, STM, SMM and IADM
Fig. 3a–e. Horizontal profiles
drawn across the middle trans-
axial image shown in Fig. 2 at
the level of the thalamus, com-
paring reconstructions guided
by MTM (solid line), and alter-
native attenuation correction
methods (dashed line).
a UFEM, b ACDM, c STM,
d SMM and e IADM
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physicians. A merely qualitative analysis revealed the
merits of the more exact methods based on realistic non-
uniform attenuation maps. They produce less visible arte-
facts, while the approximate methods tend to produce an
artefact in which there is a high level of activity along the
edge of the image due to overestimation of the head con-
tour when using ACDM on the outer slices. In addition,
horizontal profiles drawn across the middle transaxial im-
age shown in Fig. 2 at the level of the thalamus are shown
in Fig. 3 to further illustrate the noise level and quantita-
tive performance when comparing reconstructions guided
by MTM and alternative attenuation correction schemes.
The segmented transmission-based reconstruction method
overestimates the activity concentration in the central part,
with corresponding slight underestimation at the extremi-
ties (Fig. 3c). This might be explained by similar variation
in values of attenuation coefficients between non-seg-
mented and segmented attenuation maps [19]. More sig-
nificant underestimation in the central part was observed
in the case of IADM (Fig. 3e), which can be explained in
part by the large sinus cavity in corresponding planes.
Quantitative analysis
Absolute quantitation. Figure 4 shows mean square er-
rors (MSE) between the different attenuation maps as
compared to MTM, considered as the “gold standard”
for each of the ten patients studied in this work. The
MSE between MTM and the different attenuation maps
is larger when using ACDM owing to the fact that the
current implementation of this method results in signifi-
cant overestimation of the contours on the external slic-
es. Correlation plots between average absolute rCGM
values obtained from reconstructions of clinical 3D brain
scans guided by MTM and alternative attenuation cor-
rection methods using a total of 200 data points are illus-
trated in Fig. 5. The line connecting the data points rep-
Fig. 4. Mean square errors (MSE) between the different attenua-
tion maps as compared to the gold standard (MTM) for the ten pa-
tients studied
Fig. 5a–e. Correlation plots be-
tween mean absolute rCGM
values obtained from recon-
structions of clinical 3D brain
scans guided by measured
transmission and alternative at-
tenuation correction methods.
A total of 200 data points (ten
patients and 20 VOIs) are
shown. a UFEM and MTM,
b ACDM and MTM, c STM
and MTM, d SMM and MTM
and e IADM and MTM. Corre-
lation coefficients and best fit
equations are also shown
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resents the results of linear regression analysis. Correla-
tion between the mean regional cerebral glucose metabo-
lism (rCGM) values obtained with the various attenua-
tion correction methods and those obtained with the gold
standard (MTM) was good, except in the case of ACDM
(R2=0.54). The STM and SMM methods showed the best
correlation (R2=0.90) and the regression lines agreed
well with the line of identity. It is worth emphasising that
the analysis of only 20 VOI data points belonging to a
single patient followed the same pattern with respect to
best- and worst-case regression. Figure 6 shows relative
differences between absolute rCGM estimates for clini-
cal 3D brain reconstructions when using different attenu-
ation correction schemes as compared to MTM. Relative
differences in mean rCGM values were in general less
than 8%. The difference in average rCGM values be-
tween UFEM and MTM varied between 0.3% and 4.5%
for all VOIs.
The quantitative VOI-based analysis revealed differ-
ent performance characteristics and statistically signifi-
cant differences between the various correction tech-
niques when compared to the gold standard (MTM) for
some regions of the brain. Table 1 summarises the results
obtained using repeated ANOVA analysis comparing ab-
solute rCGM estimates obtained from clinical brain PET
reconstructions. Metrics include ANOVA significance,
paired sample correlation and paired sample significance
(the last two are not shown). Overall, individual VOI
standard deviations were significantly smaller for calcu-
lated and segmented-based attenuation correction algo-
rithms compared with MTM. The pons and thalamus
VOIs showed the highest probability of a true difference
for both STM and SMM methods (P≤0.0025), while
right parietal and temporal lobe VOIs, as well as right
thalamus and right head of caudate nucleus VOIs, had
the highest correlation coefficients relating MTM and al-
ternative attenuation correction schemes, except in the
case of ACDM (Table 1).
Relative quantitation. Correlation for all VOIs and all
patients between relative rCGM values normalised to the
cerebellum obtained from reconstructions of clinical 3D
brain scans guided by measured transmission and alter-
native attenuation correction schemes was found to be
high (not shown). Box and whisker plots for assessment
of contrast between the corpus callosum and the lateral
ventricle and uniformity in the cerebellum when using
different attenuation correction schemes are illustrated in
Figs. 7 and 8, respectively. The analysis of contrast as-
sessment between the corpus callosum and the lateral
ventricle when using different attenuation correction
schemes revealed significantly lower estimates when us-
ing MTM and STM, the former being noisier than all
other methods. Although the reasons for the improve-
Fig. 6a–e. Relative difference
between absolute rCGM esti-
mates for clinical 3D brain re-
constructions when using the
different attenuation correction
techniques as compared to 
the gold standard (MTM).
a UFEM, b ACDM, c STM,
d SMM and e IADM. See 
Table 1 for abbreviations
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ment in the contrast when using non-uniform attenuation
maps derived from either Atlas or patient-specific MR
images seem obvious, the explanation for this improve-
ment when using approximate methods (UFEM and
ACDM) is not clear. No significant differences were no-
ticed with respect to uniformity assessment when using
the different attenuation correction schemes investigated
in this study. Again, MTM exhibited the highest SDs,
which can be explained by significant propagation of sta-
tistical noise from short transmission scans to emission
data.
The results of statistical analysis comparing relative
rCGM estimates obtained from clinical brain PET recon-
structions based on different attenuation correction
schemes as compared to reconstructions guided by mea-
sured transmission are summarised in Table 2. The num-
ber of VOIs showing a high probability of a true differ-
ence increased substantially after normalisation to the
Table 1. Summary of statistical assessment using repeated AN-
OVA analysis for comparison of absolute rCGM estimates ob-
tained from clinical brain PET reconstructions based on different
attenuation correction techniques as compared with reconstruc-
tions guided by measured transmission (MTM), which served as
the gold standard. Metrics shown were limited to ANOVA signifi-
cance level corrected for multiple comparisons
Volume of interest UFEM ACDM STM SMM IADM
Left frontal lobe (LFL) 0.499 0.017 0.652 0.502 0.160
Right frontal lobe (RFL) 0.078 0.057 0.659 0.191 0.123
Left parietal lobe (LPL) 0.621 0.037 0.115 0.413 0.518
Right parietal lobe (RPL) 0.108 0.039 0.318 0.323 0.213
Left temporal lobe (LTL) 0.101 0.342 0.300 0.154 0.608
Right temporal lobe (RTL) 0.139 0.868 0.076 0.488 0.794
Left occipital lobe (LOL) 0.155 0.082 0.002a 0.008 0.047
Right occipital lobe (ROL) 0.068 0.145 0.002a 0.517 0.323
Left cerebellum (LC) 0.011 0.178 0.613 0.020 0.336
Right cerebellum (RC) 0.036 0.137 0.271 0.007 0.118
Cingulate gyrus (CG) 0.708 0.562 0.068 0.222 0.965
Pons (P) 0.469 0.032 0.003 0.001a 0.135
Left thalamus (LT) 0.110 0.499 0.003 0.002a 0.023
Right thalamus (RT) 0.047 0.137 0.005 <0.001a 0.002a
Left putamen (LP) 0.622 0.464 0.051 0.190 0.605
Right putamen (RP) 0.266 0.611 0.027 0.037 0.087
Left hippocampus (LH) 0.316 0.422 0.982 0.454 0.478
Right hippocampus (RH) 0.417 0.313 0.374 0.092 0.304
Left head of caudate nucleus (LHCN) 0.157 0.177 0.114 0.053 0.864
Right head of caudate nucleus (RHCN) 0.871 0.197 0.004 0.009 0.028
a Regions showing highest probability of a true difference
Fig. 7. Box and whisker plot for contrast assessment between the
corpus callosum and the lateral ventricle when using different at-
tenuation correction schemes
Fig. 8. Box and whisker plot for uniformity assessment in the cer-
ebellum when using the different attenuation correction techniques
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Table 2. Summary of statistical assessment using repeated AN-
OVA analysis for comparison of relative rCGM estimates obtained
from clinical brain PET reconstructions based on different attenua-
tion correction techniques as compared with reconstructions guid-
ed by measured transmission (MTM), which served as the gold
standard. Metrics shown were limited to ANOVA significance lev-
el corrected for multiple comparisons
Volume of interest UFEM ACDM STM SMM IADM
Left frontal lobe (LFL) <0.001a <0.001a 0.952 <0.001a 0.017
Right frontal lobe (RFL) <0.001a <0.001a 0.846 0.029 0.668
Left parietal lobe (LPL) 0.006 0.002a 0.140 0.002a 0.074
Right parietal lobe (RPL) <0.001a <0.001a 0.661 0.006 0.942
Left temporal lobe (LTL) 0.110 <0.001a 0.440 <0.001a 0.021
Right temporal lobe (RTL) <0.001a 0.002a 0.250 0.001a 0.201
Left occipital lobe (LOL) <0.001a <0.001a <0.001a <0.001a 0.003
Right occipital lobe (ROL) <0.001a <0.001a 0.002a <0.001a 0.022
Left cerebellum (LC) 0.470 0.533 0.260 0.069 0.200
Right cerebellum (RC) 0.470 0.583 0.289 0.058 0.203
Cingulate gyrus (CG) 0.013 0.002a 0.017 0.187 0.149
Pons (P) 0.070 0.033 <0.001a 0.027 0.604
Left thalamus (LT) 0.393 0.094 <0.001a 0.339 0.346
Right thalamus (RT) 0.570 0.877 <0.001a <0.001a 0.006
Left putamen (LP) 0.040 0.002a 0.003 0.002a 0.187
Right putamen (RP) <0.001a <0.001a <0.001a 0.132 0.805
Left hippocampus (LH) 0.001a <0.001a 0.386 0.001a 0.063
Right hippocampus (RH) 0.004 0.001 0.085 0.597 0.593
Left head of caudate nucleus (LHCN) 0.582 0.685 0.017 0.078 0.125
Right head of caudate nucleus (RHCN) 0.060 0.590 <0.001a 0.331 0.753
a Regions showing highest probability of a true difference
cerebellum for all methods except IADM. Nevertheless,
higher correlation coefficients were obtained on semi-
quantitative estimates.
Discussion
A clinical diagnosis from PET is usually determined by
visual inspection or semi-automated methods combined
with absolute or semi-quantitative estimates of parame-
ters of clinical interest. The impact of the attenuation
map on image quality and quantitative analysis of SPET
data, as well as differences between the effectiveness of
uniform versus non-uniform attenuation maps, has been
extensively studied [2, 11, 12, 13, 14]. Surprisingly,
however, very few studies have addressed this issue us-
ing 3D PET images. More importantly, published results
have generally been limited to conventional calculated
versus transmission-based attenuation correction tech-
niques implemented within software provided by scanner
manufacturers [3, 4, 26]. Continuous efforts to develop
robust approaches for determination of the attenuation
map in brain PET imaging without transmission scan-
ning have resulted in the proposal of several methods,
including the inferring-attenuation distributions method
based on deformable registration with respect to the
brain component of a digital head atlas [9], the automat-
ed three-component method [8], and determination of the
patient-specific head contour using an optical tracking
system combined with a reference head transmission
scan [27]. In concordance with observations by Stodilka
et al. [9] and Arlig et al. [12], the sinus of the Zubal head
phantom appears to be larger than usual. New phantom
models based on average patient populations may not
help to solve this problem owing to the large variability
in size and shape of the frontal sinus among patients.
The initiative of using other diagnostic imaging mo-
dalities to determine the attenuation map based on image
segmentation is not new since one of the major advanta-
ges of hybrid PET/CT is the ability to use the CT data
for the purpose of attenuation correction [28]. However,
the use of MRI for attenuation correction is new, and the
proof of principle has been described elsewhere [10].
The applicability of this method in a clinical environ-
ment for tracers other than 18F-FDG needs to be investi-
gated further as it depends to a large extent on the accu-
racy achieved by the co-registration algorithm, especial-
ly in neuroreceptor studies, where inter- and intramodali-
ty registration is difficult to achieve. In our preliminary
study, co-registration between PET and MR images us-
ing the AIR algorithm had an accuracy limit of less than
2 mm [21], which in our opinion is better than uncertain-
ties associated with misalignment between emission and
pre-injection TX images. Theoretically, high-resolution
MRI should provide more accurate attenuation maps for
the purposes of attenuation correction and quantification
of brain PET images. The widespread availability of MR
images for patients undergoing cerebral PET scanning
further motivates the improvement of this approach. In
addition to the extra radiation absorbed dose to staff and
patients when transmission scanning is performed, the
choice of this method for determination of the patient-
specific attenuation map has direct consequences for the
total acquisition time, PET camera time planning and
hence patient throughput.
There was a very good correlation (R2=0.90) between
rCGM estimates with all attenuation correction tech-
niques and that with MTM, and the regression lines
agreed well with the line of identity except in the case of
ACDM (R2=0.54). Similar observations were made re-
garding ACDM with respect to the dispersion of data
points, which was insignificant for all other techniques.
In addition, the general trend as shown by the regression
lines was that the coefficients of variation were similar
with the exception of ACDM. However, it should be not-
ed that ACDM led to 1% lower overall estimates than
MTM, whereas SMM led to 1.9% higher estimates. A
slightly higher correlation coefficient was obtained when
using SMM while the regression line agreed better with
the line of identity when using STM on both absolute
and relative quantitative estimates (Fig. 5). The poorest
correlation was observed for ACDM in both cases. The
choice of the optimal attenuation correction procedure
could have important clinical consequences. Van Laere
et al. [2] reported that transmission-based attenuation
correction produces a slight increase in inter-subject
variability. Since our study encompassed a limited set of
clinical data, further research is essential in various pa-
tient populations to establish the full clinical impact of
the different attenuation correction techniques assessed
in this work.
Different approaches have been suggested to judge
image quality when evaluating image correction and re-
construction algorithms. In the simplest approach,
trained nuclear medicine physicians carry out observer
performance studies and are asked to rank images by
their degree of quality. A common method for assess-
ment of image quality with respect to a detection task is
the use of observer studies, where the performance of
any observer (human or computer algorithm) is charac-
terised by receiver operating characteristics (ROC) anal-
ysis. In such studies, observers rate images based on
their confidence that a defect/lesion exists in a large set
of images. Curve-fitting methods are used to fit the rat-
ing data to ROC curves, which plot the co-variation in
“true positive” and “false positive” conditional probabil-
ities summarising how accurately those image ratings
could be used to separate the actually abnormal cases
from the normal cases [29]. The estimated area under the
fitted ROC curve is often used as a general index of im-
age quality or performance accuracy for any alternative
classification task. ROC and localisation ROC (LROC)
techniques have been extensively used to evaluate lesion
detectability. However, such techniques rely on experi-
mental phantom measurements or simulated data since
the ground truth needs to be known. Therefore, our qual-
itative assessment was restricted to subjective observer
rating scores by two experienced physicians. An interest-
ing approach in future comparative evaluation studies
would be to carry out voxel-based statistical analysis us-
ing SPM. Our recent study on the impact of model-based
scatter correction and iterative reconstruction on spatial
distribution of 18F-FDG in reconstructed brain PET im-
ages of healthy subjects using this kind of analysis dem-
onstrated that iterative reconstruction does not result in
significant changes when compared with analytic recon-
struction procedures, while significant differences in 18F-
FDG distribution arise when images are reconstructed
with and without explicit scatter correction for some ce-
rebral areas [30]. This needs to be acknowledged for ad-
equate interpretation of 3D brain PET images after ap-
plying scatter correction.
One of the motivations for the development of SMM
is to achieve accurate quantitative accuracy with a trans-
mission-less brain PET tomograph. Removal of the
transmission scanning component simplifies greatly the
complexity of the tomograph’s design and acquisition
protocols and contributes significantly to lowering the
cost of the prototype. In fact, our group is involved with-
in the Computed Imaging for Medical Applications
(CIMA) collaboration in the design of a novel and inno-
vative high-resolution Compton-enhanced 3D brain PET
tomograph dedicated to brain research (patent applied
for, PCT/EP 02/07967) [31]. This concept leads to an
image reconstruction which is free of any parallax error
and provides a uniform spatial and energy resolution
over the whole sensitive volume. The key components
are a matrix of long scintillator crystals and Hybrid Pho-
todiodes (HPD) with matched segmentation and integrat-
ed readout electronics.
It is recognised that this study included a restricted set
of patients and did not encompass experimental phantom
studies for detailed characterisation of the different
methods in a controlled manner. The use of phantom
studies where ground truth can be established would al-
low for a quantitative understanding of the source and
magnitude of errors in the attenuation and emission data.
Future work will concentrate on similar studies using a
fully tissue-equivalent anthropomorphic head phantom
manufactured by RSD (Radiology Support Devices,
Long Beach, CA) when it becomes available in our de-
partment. Nevertheless, the segmented MRI-guided at-
tenuation correction technique cannot be evaluated using
such a phantom. Another aspect that deserves further at-
tention with emerging applications of dual-modality
PET/CT imaging devices in clinical routine is the inves-
tigation of the limitations of CT-based attenuation cor-
rection in the presence of metallic dental implants, which
are known to introduce significant artefacts not only on
CT but also on radionuclide transmission scans and
therefore the reconstructed brain PET images [32]. In-
vestigation of the potential of the different methods in-
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vestigated in this study as compared to the CT-based ap-
proach is strongly needed.
Conclusion
The attenuation map influences both absolute and rela-
tive quantitation in cerebral 3D PET. The quantitative
VOI-based analysis revealed different performance char-
acteristics and statistically significant differences be-
tween the different attenuation correction techniques
when compared with the gold standard (MTM). Trans-
mission-less attenuation correction results in a reduced
radiation dose and makes a dramatic difference in acqui-
sition time. The necessity of acquiring an additional TX
scan is a restrictive factor for patient throughput. Consid-
ering the difficulties associated with TX-based attenua-
tion correction and the limitations of the current calculat-
ed attenuation correction methods, MRI-guided attenua-
tion correction in 3D brain PET would likely be the
method of choice for the foreseeable future as the best
approach in a brain PET research facility and could be
applied to other functional brain imaging modalities (e.g.
SPET). This might also have consequences for future de-
signs of PET cameras dedicated to brain research, where
addition of a transmission scanning component will pos-
sibly be unnecessary, thereby simplifying the complexity
of the tomograph’s design and lowering its cost [31].
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